microRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer

BACKGROUND: One-third of cervical cancer patients are still diagnosed at advanced stages. The five-year survival rate is decreased in about 50% of advanced stage cervical cancer patients worldwide, and the clinical outcomes are remarkably varied and difficult to predict. One of the miRNAs known to b...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Sunyoung, Kim, Jungho, Eom, Kiyoon, Oh, Sehee, Kim, Sunghyun, Kim, Geehyuk, Ahn, Sungwoo, Park, Kwang Hwa, Chung, Dawn, Lee, Hyeyoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501303/
https://www.ncbi.nlm.nih.gov/pubmed/31060525
http://dx.doi.org/10.1186/s12885-019-5620-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501303/
https://www.ncbi.nlm.nih.gov/pubmed/31060525
http://dx.doi.org/10.1186/s12885-019-5620-6

Ejemplares similares